Rare Disease Registries: Practical Ways to Build Trust with Patient Advocacy Groups
1:02:03
Description
Related Videos
With the right planning and understanding, collaboration between drug development companies and patient advocacy groups (PAGs) can be mutually beneficial in a number of key areas.
View More
View Less
